A philosophy of advanced clinical skill and artistry Natural results are not accidental
Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrm SZ, Davies MJ, Hovingh GK, Kitzman DW, Mller DV, Verma S, Einfeldt MN, Lindegaard ML, Rasmussen S, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Things like access, cost, staying on treatment, and long-term habits all play a role
It tells you whether you are in the early escalation phase, the middle titration period, or the maintenance stage
Keywords: Basal insulin, GLP-1, Glycaemic control, Network meta-analysis, Semaglutide, Systematic review, Type 2 diabetes Key Summary Points Digital Features This article is published with digital features, including a summary slide, to facilitate understanding of the article